Topics
Gliomas | Treatment | Clinical trials | LB100
Home > Publications > Topics > Gliomas > Treatment > Clinical trials > LB100
Burton EC, Walker E, Boris L, Reyes J, Fernandez K, Wall K, Wu J,
Schmidt KT, Figg WD, Brown DA.
A Phase
0 Window of Opportunity Trial of
LB100,
a Protein Phosphatase 2A Inhibitor, in Patients with Recurrent
Gliomas.
medRxiv
[Preprint]. 2025 Aug 21:2025.08.18.25333496. doi:
10.1101/2025.08.18.25333496. PMID:
40894137.Interventional study. ˍ